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Objectives: Art therapy (AT) as a treatment option for anxiety is regularly employed
in clinical practice, but scientific evidence for its effectiveness is lacking, since this
intervention has hardly been studied. The aim was to study the effectiveness of AT on
anxiety in adult women. The specific type of AT studied was anthroposophic AT.
Methods: A RCT comparing AT versus a waiting list (WL) condition on anxiety
symptom severity, quality of life, and emotion regulation. Factors influencing treatment
outcome were additionally explored. Participants were women, aged 18–65 years,
diagnosed with generalized anxiety disorder, social anxiety disorder or panic disorder,
with moderate to severe anxiety symptoms. The trial was registered in the Dutch Trial
Registration (NTR28143).
Results: Fifty-nine women were included, of which 47 completed the trial. Both per-
protocol and intention-to treat analyses demonstrated effectiveness of AT compared
to WL, showing a reduction in anxiety, an increase in subjective quality of life (both
with large effects) and an improvement in accessibility of emotion regulation strategies
(medium effect). Treatment effects remained after 3 months follow-up. Improved
acceptance of emotions and improved goal-oriented action are aspects of emotion
regulation that are associated with the decrease in anxiety level.
Conclusion: AT is effective in reducing anxiety symptoms, improving quality of life and
aspects of emotion regulation. Future RCTs should use active controls (treatment as
usual) and study cost-effectiveness.
Keywords: anxiety, anxiety disorders, art therapy, emotion regulation, generalized anxiety disorder, social anxiety
disorder, panic disorder, social phobia
Abbreviations: AAT, anthroposophic art therapy; AD, anxiety disorder; AT, art therapy; ER, emotion regulation; WL,
waiting list.
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Nearly 29% of the population will be affected by an AD
somewhere in life (Kessler et al., 2005). It is estimated
that currently 264 million people live with ADs, and this
number increased between 2005 and 2015 with 14,9%
(World Health Organization, 2017).
The presence of an AD is associated with a lower quality of
life (QoL) and a negative impact on psychosocial functioning
(Mendlowicz and Stein, 2000; Cramer et al., 2005). The most
common ADs that have an impact on daily life are social
anxiety disorder (SAD), generalized anxiety disorder (GAD),
and panic disorder (PD) (Anxiety and Depression Association
of America [ADAA], 2018). Cognitive behavioral (CBT) and
pharmacological therapy (PT) proved to be effective methods
for reducing anxiety symptoms (e.g., Kjernisted and Bleau, 2004;
Pohl et al., 2005; Hooke and Page, 2006; Hofmann and Smits,
2008). However, ADs have a recurrence rate of 54,8% within
4 years, diagnostically instable recurrences included (Scholten
et al., 2016) and a substantial portion of individuals does not
benefit from these standard treatments. Not only does PT cause
side effects, but also between 20 and 50% of patients have
either a contra-indication or don’t respond to PT (Lydiard et al.,
1996; Davidson et al., 2004; Blanco et al., 2010; Hyman, 2010).
Combination of PT with CBT is recommended (Bandelow et al.,
2012) but around 50% of individuals with ADs do not benefit
from CBT (Nielsen et al., 2018), or prefer not to take medication,
or prefer non-verbal therapy (Uttley et al., 2015). These groups of
individuals may benefit from AT.
Art Therapy
Art therapy is a non-verbal, experience-oriented therapy that uses
the visual arts (e.g., painting, drawing, sculpting, clay modeling)
and is provided as standalone therapy or in multidisciplinary
treatment programs for anxiety. The non-verbal AT approach
is considered to be suitable for individuals with of anxiety,
especially if they have difficulty in cognitive (re)labeling of their
feelings, or if they are very focused on cognitive labeling and use
rationalizing as a psychological coping mechanism (Gold et al.,
2004; Smeijsters, 2008). Moreover, the non-verbal AT approach is
considered to be suitable for patients with high levels of anxiety,
since talking about anxiety and traumas can evoke fear and
associated physical reactions (Posthuma, 2001). It is stated that
distance to the anxiety can be provided when creating visual
art work. To ‘distance’ oneself from the emotion during the act
of creating art is believed to improve cognitive regulation of
emotions (Smeijsters, 2008). The supposed mechanism is that
during the process of creating an art work, one can experience
a feeling of being ‘in control,’ which helps to counterbalance the
overwhelming experience of anxiety (Van Gerven, 1996).
The effectiveness of AT on reducing anxiety symptoms
in adults has hardly been studied in randomized controlled
trials (RCTs). There are some indications for effectiveness in
different populations, but most of these studies have considerable
methodological flaws leading to high risk of bias and are
therefore of low quality (Abbing et al., 2018). There is some
evidence for effectiveness of AT for treating pre-exam anxiety
FIGURE 1 | The effectiveness of art therapy in the treatment of anxiety in adult women: a randomized controlled trial.
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in undergraduate students (Sandmire et al., 2012) and pre-
release anxiety in male prisoners (Zhan Yu et al., 2016).
There are no studies on specific ADs like GAD, SAD, or PD
(Abbing et al., 2018).
Art therapy has a variety of subtypes, that are based on
various perspectives from psychoanalysis, cognitive-analytic
therapies, compassion-focused therapy, attachment-based
psychotherapy and client-centered approaches, like mindfulness
and mentalization-based treatments (British Association of Art
Therapists [BAAT], 2018). One of the AT variants with a client-
centered approach and with similarities to mindfulness-based
treatments is AAT.
An expressive approach is common in most AT interventions
(British Association of Art Therapists [BAAT], 2019), in which
the client is guided to express feelings, thoughts and life
experiences. This approach is also used in AAT, but is combined
with an ‘inwardly oriented’ approach, where the therapist offers
specific artistic exercises that are often structured and aim to
provide ‘impressions’: profound experiences of color and shape.
These are thought to activate and strengthen the self-regulating
ability of the client.
An important feature of anxiety is the exaggerated cognitive
appraisal that is associated with the threatening situation: hyper-
alert cognitive schemes lead to pathological anxiety (Beck and
Haigh, 2014). The rationale behind AAT is that excessive talking
about the anxiety is avoided, to enable patients to deviate from
‘the thinking-mode’ into a ‘feeling-mode’: the aim is to support
the individual to obtain ‘profound connection to embodied
experiences’: to become aware of the anxiety feelings and
responses in the body and learn to influence (downregulate) these
feelings, by practicing and experiencing. These processes are
thought to be supported through various artistic exercises. The
effectiveness of AAT and its working mechanisms is, however,
hardly studied and there is currently no adequate theoretical
background that provides insight in the specific processes that are
influenced by the therapy.
Emotion Regulation
Individuals with an AD have more difficulty in regulating
emotions compared to individuals without anxiety problems
(Suveg and Zeman, 2004; Mennin et al., 2005) and are
characterized by dysfunctional ER strategies (Cisler et al., 2010;
Ziv et al., 2013; Jazaieri et al., 2014; Diefenbach et al., 2016).
People with (for example) GAD have developed an increased
intensity of emotions, a lack of understanding of emotions, fear
for the emotion, and their response to the emotion is inadequate
(Mennin et al., 2002, 2004).
Emotion regulation refers to the intrinsic and extrinsic
processes that influence the way in which emotions are
expressed or suppressed and are given meaning to, conscious
as well as unconscious (Gross and Thompson, 2007). Gratz
and Roemer (2004) developed a concept of ER, which involves
the “awareness and understanding of emotions, acceptance of
emotions, ability to control impulsive behaviors and behave
in accordance with desired goals when experiencing negative
emotions, and the ability to use situationally appropriate ER
strategies flexibly” (Gratz and Roemer, 2004, pp. 42–43). ER
can be improved through training and therapy (Baumeister
et al., 2006; Tang and Posner, 2009). Artistic exercises, like
for example expressive writing, can downregulate emotional
distress and promote self-insight (e.g., Pennebaker and Chung,
2007), Thus, ER is an important factor in evaluating AT
treatment effects. The connection between AT and ER has
already been studied and preliminary established in a narrative
review on effectiveness studies (Gruber and Oepen, 2018),
primarily focusing on changes in mood in healthy subjects.
To gain more insight in the working mechanism(s) of AT on
anxiety, it is important to not only investigate the effectiveness
of AT on anxiety symptom severity, but also simultaneously
explore the role of ER.
Rationale and Objectives
Rationale
Given the need for evidence-based additional treatments for
ADs and the lack of methodologically sound effectiveness studies
on AT for these indications (Abbing et al., 2018), we designed
and executed a study on the effectiveness of AT in reducing
anxiety in adult women.
Objectives
The primary objective was to assess the effectiveness of AT on
anxiety and QoL in women with ADs.
The secondary objective was to explore factors influencing
treatment outcome.
MATERIALS AND METHODS
The CONSORT-NPT statement was used for reporting
this trial, which is the extension of the CONSORT for
randomized trials assessing non-pharmacologic treatments
(NPTs) (Boutron et al., 2017).
Trial Design
The effectiveness of ATAT on anxiety symptoms in adult women
was studied within a RCT. The trial was pragmatic in the sense
that it aimed to study the effectiveness of the intervention as
it is normally practiced in the field. Participants were pre-
stratified on comorbid depression and on psychopharmaceuticals
use (see section “Randomization Method and Allocation
Concealment”) and subsequently randomly assigned to an
experimental group receiving anthroposophic AT (AT1 group)
or a control group with participants on a waiting list (WL
group), continuing their current treatment, if any, for 3 months.
Both groups were measured at baseline (pre-test/T0) and after
the intervention/waiting time at 3 months (post-test/T1). The
control group then received the intervention (AT2 group) and
was assessed immediately after intervention at 3 months. The
experimental group was also assessed after 3 months (follow-
up/T2) (Figure 2).
Ethical approval was obtained from the Medical Ethical
Committee of the Leiden University Medical Centre, Netherlands
(NL36861.018.11) and the trial was registered in the Dutch Trial
Registration (NTR28143).
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FIGURE 2 | Trial design. AT1 group, art therapy group/experimental group; WL group, waiting list group/control group; AT2 group, second treatment group.
Participants
Participants were recruited through posters/flyers in the
practices of family doctors and by social media. Information
about the trial was provided through a website where patients
could register by filling out a screening instrument [the Dutch
version of the Four Dimension Symptoms Questionnaire
(4DKL)] (Terluin, 1996; Terluin et al., 2004). Women
with moderate to severe anxiety symptoms, scoring >7 for
anxiety and/or >10 for distress on the 4DKL (Terluin and
Duijsens, 2002), were contacted by phone for eligibility
assessment. The inclusion was dimensional in nature:
subjects were included primarily based on the level of
anxiety symptoms.
Included were adult woman (18–65 years), with GAD,
SAD and/or PD (with or without agoraphobia) (diagnosed by
means of the MINI-plus diagnostic interview (Sheehan et al.,
1998). Candidates were excluded if they had suffered from
psychosis or hallucinations, alcohol or drug addiction, suicidal
risk and/or brain pathology. Including only women was a post-
recruitment decision, since only one male subject fulfilled the
inclusion criteria.
Participants signed the informed consent that was approved
by the Medical Ethical Committee.
Intervention and Procedure
The study took place at 25 private AT practices spread
throughout the Netherlands, in the period between January
2017 and March 2018.
After randomization AT-participants received 10–12 indivi-
dual AT sessions of 45–60 min per session during 3 months.
Treatment was provided only by qualified and registered
Dutch anthroposophic art therapists, with more than 5 years’
experience in working with adults with anxiety. By only including
therapists that fulfill the quality criteria stated by the professional
organization, it was assured that the intervention deployed in the
study was representative for the general approach in AAT.
The treatment was based on common practice and consensus
within the Dutch professional association of anthroposophic art
therapists (NVKT): first to third session involve intake and free
art work, after which treatment goals are set and a therapy plan
is made by the therapist, based on intake and observation of
client and art work (Huber et al., 2003). This plan consists of a
variety of artistic exercises that could be chosen from a list with
treatment goals and AT activities, based on consensus within the
professional association (Table 1). No fixed treatment protocol




Set treatment goals and
plan
Free art work
Sessions 4–10 Optional treatment goals:







Other treatment goals are
allowed; mention these
treatment goals here and
describe why these are
important in the treatment
of your client.
Optional artistic exercises:
• Clay: Clay modeling of a
sphere.




Expression of fear in free drawing.
Atmospheric images in relation to




charcoal. Color exercises with
pastel.
• Painting: Expression of fear in
free painting. Color exercises in
wet-on-wet technique (aquarelle
paint on wet paper).
Other exercises are allowed;
provide rationale for these
exercises and a description.
Session 12 Evaluation
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was used since anthroposophic AT is a highly individualized
treatment. Instead, the exercises on the list could be chosen
and adapted to the individual patient, each session taking into
account the patients’ specific context. The overview listed several
exercises within three media: drawing, painting and clay work
(Table 1). The contents of the therapy processes (treatment goals
and exercises) were documented by the therapists. Afterward,
researchers checked if the deployed activities fulfilled the list of
treatment goals and exercises. The WL participants were on the
WL for 3 months and received AT 3 months later (Figure 2).
Measures
The following measures were used for screening, diagnosing and
determining anxiety symptom severity, QoL, and ER.
Screening for Psychological Problems
Participants were screened by the 4DKL (Terluin, 1996). This
is a questionnaire for adolescents and adults and screens on
psychological problems with 50 items, measuring symptoms of
distress, depression, anxiety, and somatic symptoms. Anxiety
symptoms are measured by 12 items. This instrument is reliable
and valid (Egberink et al., 2005).
Diagnostic Interview for Anxiety Disorders and
Comorbidity
Psychopathology was assessed using the Dutch version of
the rater-administered Mini International Neuropsychiatric
Interview Plus (MINI-Plus) (Van Vliet et al., 2000), which is
a comprehensive diagnostic semi-structured interview. In the
present study, the MINI-Plus was used to assess the type(s) of AD
and the presence of (comorbid) depression, PTSS and substance
abuse (exclusion criterium).
Primary Outcome: Level and Dimensions of Anxiety
The Dutch version of the Lehrer Woolfolk Anxiety Symptom
Questionnaire (LWASQ) (Lehrer and Woolfolk, 1982) was used
to measure the anxiety level. The LWASQ is a self-report,
generic anxiety instrument with 36 questions which assesses the
cognitive (worry and rumination), behavioral (avoidance) and
somatic (physical symptoms) aspects of anxiety. The reliability
of the LWASQ is sufficient (α = 0.83 to 0.92) and the
questionnaire is suitable for the measurement of treatment effects
(Scholing and Emmelkamp, 1992).
Secondary Outcomes: Subjective Quality of
Life and Emotion Regulation
The Dutch version of the MANchester Short Assessment of
QoL (MANSA) (Priebe et al., 1999; Van Nieuwenhuizen et al.,
2000) was used to measure QoL. This instrument consists of 12
questions that measure the satisfaction with, e.g., life in general,
work and friendships. The MANSA is a reliable instrument
(Janssen-de Ruiter et al., 2015).
To measure the difficulties that patients experience in ER, the
Dutch version of the Difficulties in Emotion Regulation Scale
(DERS) (Gratz and Roemer, 2004) was used. The questionnaire
consists of 36 items in six domains: (1) lack of clarity of emotions,
(2) lack of awareness of emotions, (3) difficulty in controlling
TABLE 2 | Procedure.
Phase I Phase II
T0 T1 (+3 months) T2 (+3 months)
AT1 Pre-treatment Post-treatment Follow-up
WL Pre-wait time Post wait time/Pre-treatment AT2 Post-treatment AT2
impulses, (4) non-acceptance of emotions, (5) limited access
to ER strategies, and (6) difficulty with goal-oriented action
(Gratz and Roemer, 2004).
The DERS can be reliably deployed and interpreted in different
demographic groups (Ritschel et al., 2015). The construct validity
and internal consistency (Cronbach’s α > 0.80) is sufficient for
all scales (Gratz and Roemer, 2004; Neumann et al., 2010). The
test–retest reliability for the total score is good (r = 0.88; subscales
0.56 < r < 0.90).
Procedure of Measurements
All participants completed online assessments of the 4DKL,
LWASQ, MANSA, and DERS at three time points (Table 2).
All questionnaires were administered with Qualtrics
Survey Software (Qualtrics Software (2005), Provo, UT,
United States, version 2017).
Sample Size
Sample size calculation was based on a pre–post measurement
difference in the primary outcome of 15% (as this was considered
a clinically relevant decrease in LWASQ total score), with an
alpha of 0.05 and a power of 0.80. Considering a dropout rate of
15%, the estimated sample size was 30 patients per group; a total
of 60 participants1.
Randomization Method and Allocation
Concealment
Participants were pre-stratified into four strata: whether or not
using psychotropic drugs, and whether or not having moderate
or severe depression symptoms (4DKL: depression > 6), and
subsequently assigned to treatment (AT) or control group (WL)
by means of block randomization (blocks of 2) (Figure 3).
Participants received a participation number at enrolment.
After enrolment and stratification of participants by AA, a
list with the random allocation sequence was generated by
EB through computer selection2. AA assigned participants to
intervention according to the randomization list.
Art therapists and participants could not be blinded.
Statistical Methods
Statistical analyses were conducted using SPSS statistics
(version 23.0) (IBM Corp., 2015). All data were checked
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FIGURE 3 | Study flow diagram.
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Evaluation of Baseline Differences
The randomization was evaluated by comparing experimental
and control group at baseline. For normal distributed, continuous
variables an independent t-test was used and the variables were
presented as mean ± standard deviation (SD). For categorical
variables Pearson’s chi-squared test was applied and variables
were presented as number and/or percentage.
Missing Values
Reasons for missing values were reported. Dropouts were
compared to completers using pre-test measures on age, anxiety
score, depression score and QoL score, by use of independent
students t-tests. If no significant differences were found, the
missing cases were deleted and per protocol (PP) analyses were
performed for all outcomes.
For the intention-to-treat (ITT) analysis missing values on
anxiety score at baseline (T0) and T1 for all participants that
were randomized to one of the two groups were imputed
based on two theoretical models (White et al., 2011). In the
first model participants with no measurements at T0 and T1
received anxiety scores that were the mean of the condition they
were allocated to and at T1 the same score was imputed [last
observation carried forward (LOCF) procedure], expressing that
there was no treatment effect and participants were comparable
to the average participant. Participants with no measurement
at T1 received the anxiety score at T0 (LOCF procedure).
The second model was the same, with the only difference that
the participants with no measurements at T0 and T1 received
anxiety scores that were the highest possible score, expressing
the worst-case scenario that these participants were the ones with
highest anxiety level.
Hypotheses
The following hypotheses were tested: (1) AT is superior to WL in
reducing anxiety symptoms and improving QoL in adult women
with ADs; (2) the effects of AT remain at 3 months follow-up; and
(3) the effects of AT are confirmed in the WL group that receives
AT 3 months later.
Evaluation of Treatment Effects
To examine hypothesis 1, a general linear model repeated
measures analysis for variance (RM-ANOVA) was used, using
outcomes of LWASQ at pre- and post-treatment as levels of
the within-subject (WS) factor Test moment (T0 vs. T1) and
Group (AT1 vs. WL) as between-subjects (BS) factor. To conclude
that the treatment has a positive effect, the Test moment∗Group
interaction must be significant and in the right direction. To test
if reduction of anxiety was different for the three subscales of the
LWASQ, these subscales were added as levels of the WS factor
Scale in a second analysis.
Likewise, for the secondary outcomes (MANSA, DERS), RM-
ANOVAs were performed. If trend significant interactions were
found, further explorative analyses (paired t-tests) were executed
to measure within-group effects.
A PP analysis was performed for all primary and secondary
outcome variables. In addition, an ITT analysis was performed
for the primary outcome variable ‘level of anxiety.’
A p-value of 0.05 was considered statistically significant. The
effect size partial eta squared (η2p) was calculated to assess the
magnitude of the effect. An effect size of 0.01–0.06 is considered a
small effect, 0.06–0.14 a medium, and >0.14 a large effect in RM
analysis (Borenstein, 2009).
For hypothesis 2, a RM-ANOVA with Test moment (T0, T1,
T2) as WS factor on the primary and secondary outcomes of
the AT1 group was performed, to determine if treatment effects
remain for (at least) 3 months and to test if an effect (compared
to baseline) still exists, using a simple contrast with T0 as the
reference level (T0 vs. T1, T0 vs. T2).
Hypothesis 3 was tested with paired t-tests on T1–T2
outcomes (pre- vs. post-treatment) of the WL group that received
treatment (AT2).
Exploration of Factors Influencing Anxiety Reduction
To explore factors that influence anxiety symptom reduction,
correlations were computed between the primary outcome
variable (pre–post treatment difference in anxiety symptom
severity, PP analysis) and the pre–post treatment difference
scores on QoL, distress, somatization and difficulties in ER.,
Only the significant correlations were further studied with
regression analysis within the total treatment group (AT1 and
AT2 together), to examine if improvements of ER were
associated with anxiety symptom reduction. An ANCOVA with
pre- and post-treatment scores of anxiety, and the pre–post
treatment difference score of ER as covariate was performed as
post hoc analysis.
To explore pre-treatment factors that would favorably affect
the success of treatment, the same procedure was followed,
but with pre-treatment measures of age, duration of anxiety,
comorbidity (number) and level of education. Regression
analyses were conducted within the total treatment group
(AT1 and AT2 together), with the primary outcome variable
(pre–post treatment difference in anxiety symptom severity,
PP analysis) and the pre-treatment measures that showed a
significant correlation with the anxiety difference score.
RESULTS
Participant Flow
In the period January 2017 until July 2017, 102 persons applied
for the trial and were screened for eligibility. A total of 43 patients
was excluded for not meeting the inclusion criteria (n = 23) or not
willing to participate (n = 19) or for other reasons (n = 1).
In total, 59 participants were included and randomized
after stratification. The distribution over the four strata was as
follows: no depression and no psychopharmaceuticals (n = 27),
no depression and psychopharmaceuticals (n = 11), depression
and no psychopharmaceuticals (n = 14), depression and
psychopharmaceuticals (n = 7).
Thirty participants were assigned to the intervention group
(AT1) and 29 to the control group (WL). During the study,
12 participants dropped out, six from the AT1 group and six from
the WL group. Loss-to-follow-up occurred in the AT1 group
(n = 1), as well in the WL group (n = 3). In total, data of
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47 participants were analyzed in the PP analysis: 24 in the AT1
group and 23 in the WL group.
Participants of the AT1 group were followed-up around
3 months after completion of the treatment. Participants of the
WL group received AT (AT2 group) after completion of the
3 months wait time. Three participants of AT1 group were lost to
follow-up and three participants of the AT2 group did not receive
the intervention for several reasons (Figure 3).
Missing Values
Twelve participants (20%) dropped out and 47 participants
(80%) completed Phase I of the trial. There were no significant
differences between dropouts and completers on baseline
parameters: age, anxiety score (LWASQ), anxiety score (4DKL),
depression score (4DKL), distress score (4DKL), somatization
score (4DKL), and QoL (MANSA) (0.87 < p < 0.29). These
results indicate that missings were completely at random and
could be list-wise deleted, without risk of bias, and further
analyses are per-protocol.
Baseline Characteristics
Table 3 gives an overview of the baseline characteristics of
participants. The participants did not differ on key vari-
ables, including age, diagnosis, use of medication, occupation,
education, familiarity with AM and outcome variables at baseline.
The analyzed sample of 47 participants had a mean age of 44.4
years (SD = 14.0), moderate to severe anxiety symptoms: 11.2
(SD = 4.6), a mean duration of anxiety symptoms of 17.6 years
(SD = 18.9) [range: 3 months – 64 years (lifetime)]. Medication
for anxiety was used by 15 participants and 11 participants
received other therapies next to AT (psychotherapy, EMDR,
and acupuncture).
Multiple anxiety diagnoses applied to all participants
(comorbid ADs), with two to five ADs per person. The criteria
for the diagnosis GAD were met 25 times, for SAD 21 and
for PD 28 times. Ten participants suffered from (comorbid)
PTSD, five participants had current comorbid depression and
16 participants experienced one or more depressive episodes
prior to this study.
Features of the Experimental Treatment
In total, 44 participants completed the therapy, and 37 case
files were received until September 2018 and analyzed. All cases
fulfilled the criteria of an AAT intervention as described in the
study protocol: use of anthroposophic AT exercises from the
predefined list and adaptation of the intervention to the specific
context of each individual patient (optional).
Therapy plans consisted of artistic exercises in which the
media drawing and clay modeling were used most often,
respectively in 37 and 34 of the analyzed 37 cases, and painting in
21 cases. Drawing exercises consisted of shape drawing, charcoal
drawing, pastel drawing, and visualization exercises. The most
deployed techniques were shape drawing (drawing of relaxing
loops), often provided as homework exercise, the creation of
light-dark contrasts and conversions (charcoal drawing), drawing
from observation and working on atmospheric images in relation
to inner feeling (pastel drawing). The expression of the fear,
with various materials and techniques, often preceded by a
visualization exercise, was also used in most cases. Within the
clay medium, round shapes were most frequently used, as well
as the modeling of one or more platonic solids. Transformation
processes and symbolic exercises were also frequently applied
within the clay medium. Painting exercises were mainly the wet-
in-wet technique (aquarelle paint on wet paper) and were mainly
used in the first sessions as free art work. For examples, see
Figure 1 (visual abstract).
Treatment Effects – Primary Outcomes
Per Protocol Analysis
On the primary outcome anxiety symptom severity, the
interaction effect Test moment∗Group was significant: F(1,45) =
11.49, p = 0.001, with a large effect size (η2p = 0.20), showing
that anxiety was reduced in the AT1 group but not in the WL
group (see Figure 4). The three subscales of the LWASQ, added
in a second analysis as levels of the WS factor Scale, showed
no significant interaction Test moment∗Group∗Scale (p = 0.71),
reflecting that the improvements in anxiety symptom severity
hold equally for the somatic, behavioral, and the cognitive area.
The within-group outcomes (mean differences, SDs, 95% CIs
and p-values) are presented in Supplementary Table 1.
Intention to Treat Analysis
Both ITT analyses for the primary outcome (LWASQ)
demonstrate the same significant differences between the
groups: p = 0.011 with a medium effect size (η2p = 0.11).
Treatment Effects – Secondary
Outcomes
Quality of Life
The interaction Test moment∗Group was F(1,45) = 22.94,
p < 0.0001 and the effect size was large (η2p = 0.52), reflecting,
that QoL was increased in the AT group but not in the WL
group (Figure 4).
Emotion Regulation
The interaction Test moment∗Group was trend significant for
difficulties in ER (total score): F(1,45) = 3.87, p = 0.055,
and was accompanied by a medium effect size (η2p = 0.08).
Post hoc analysis confirmed that total ER improvement was
significant in the AT group (p = 0.003) but not in the WL group
(p = 0.16). On the subscale level, the only significant interaction
Test moment∗Group was on the subscale limited access to ER
strategies: F(1,45) = 6.0, p = 0.018, η2p = 0.12. This indicates that
participants had better accessibility to ER strategies after therapy.
The subscales lack of clarity of emotions, non-acceptance
of emotions, and limited access to ER strategies showed
significant improvements in the AT group (within-group
analysis) (0.008 < p < 0.05) (Table 3).
Follow-Up Outcomes in First
Treatment Condition
The first treatment group (AT1) was followed up 3 months after
treatment (n = 21). Using a simple contrast with T0 as reference
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TABLE 3 | Participants’ baseline characteristics.
AT (n = 24) WL (n = 23)
Characteristics Mean (SD) or n (%) Mean (SD) or n (%) p
Age (years) 42.4 (14) 46.5 (14) 0.32
4DKL anxiety >7 moderate; >12 severe 12.0 (4.3) 10.3 (4.9) 0.21
Anxiety score LWASQ total score 103.2 (21.4) 97.2 (21.7) 0.34
Anxiety disorder according to MINI+ GAD 14 (58%) 11 (48%) 0.47
SAD 9 (38%) 12 (52%) 0.31
PD 14 (58%) 14 (61%) 0.61
Comorbid PTSD 4 (17%) 6 (26%) 0.40
Duration Of anxiety symptoms (years) 15.1 (±18.6) 20.2 (±19.4) 0.34
4DKL distress >20 severe 23.0 (6.2) 22.6 (5.0) 0.81
4DKL depression 4,0 (2,7) 4,2 (3.3) 0.77
Depression according to MINI+ Current depression 3 (13%) 2 (9%) 0.46
Previous depression 7 (29%) 9 (39%)
Medication 7 (29%) 8 (35%) 0.51
Other therapies during study period 6 (25%) 5 (22%) 0.41
Occupation Working 6 (25%) 7 (30%) 0.52
Self employed 3 (13%) 3 (13%)
Student 2 (8%) 2 (9%)
Unemployed 3 (13%) 2 (9%)
Sick leave/incapacitated 9 (38%) 9 (39%)
Education Low 3 (13%) 2 (9%) 0.14
Moderate 9 (38%) 4 (17%)
High 11 (46%) 17 (74%)
4DKL, Four-Dimensional Symptom Questionnaire; AT, art therapy group; WL, waiting list group; Education, Low (elementary school, vmbo, mbo1), Moderate (havo, vwo,
mbo2-4), High (HBO, WO); Medication, psychotropic medication; p-values < 0.05 were considered significant.
FIGURE 4 | Primary and secondary outcomes at T0, T1, and T2. Means (SE).
level (first contrast: T0 vs. T1, second contrast: T0 vs. T2), the
RM-ANOVA on anxiety symptom severity revealed a significant
first and second contrast [FT0vs.T1(1,20) = 10,68, p = 0.004,
η2p = 0.35; FT0vs.T2(1,20) = 16.51, p = 0.001, η
2
p = 0.45]. Similar
effects were observed for QoL [FT0vs.T1(1,20) = 41.1, p < 0.0001,
η2p = 0.67, FT0vs.T2(1,20) = 12.56, p = 0.002, η
2
p = 0.39] and ER
Frontiers in Psychology | www.frontiersin.org 9 May 2019 | Volume 10 | Article 1203
fpsyg-10-01203 May 29, 2019 Time: 16:25 # 10
Abbing et al. Art Therapy for Anxiety
[FT0vs.T1(1,20) = 9.04, p = 0.007, η2p = 0.31, FT0vs.T2(1,20) = 14.43,
p = 0.001, η2p = 0.42]. The observed treatment effects on anxiety
symptom severity, QoL and ER remained at follow-up (Figure 4).
The outcomes at T2 were still significantly improved compared
to baseline (T0).
Outcomes in Second Treatment
Condition
The second treatment group (AT2, n = 20), showed similar
improvements as the first treatment group: anxiety is signifi-
cantly lowered in the AT2 condition [mean(SD)]: 95(24,10)–
77,55(21,57), p = 0.001, with a large effect size (η2p = 0.45).
However, there are some differences. The improvement in
QoL was not significant in the AT2 condition [mean(SD)]:
58,05(6,93)–60,30(9,13), p = 0.11 (η2p = 0.13), while it was highly
significant in the AT1 group. The improvement in total ER
was significant in de AT2 condition [mean(SD)]: 94,45(19,83)–
83,95(21,59), p = 0.003, (η2p = 0.38), and associated with a larger
effect size compared to the AT1 group.
Exploration of Factors That Influence
Anxiety Reduction
The total treatment group (n = 44) consisted of AT1 (n = 24) and
AT2 (n = 20). The mean difference in anxiety symptom severity
of the total treatment group was 18,68 (SD = 21,96) (95% CI:
12,01–25,36, p < 0.0001), which represents an anxiety severity
decrease of 18,6%.
Role of Emotion Regulation in Anxiety Reduction
The LWASQ difference score (pre–post treatment) was
correlated with the difference scores of the other outcomes
(MANSA, DERS). ER difference score was correlated with
anxiety symptoms (r = 0.39, p < 0.0001), reflecting that
a decrease in anxiety symptoms was associated with an
increase in ER. Looking at the subscale level, improvement
on five of the six ER subscales was associated with a
decrease of anxiety symptoms: clarity of emotions (r = 0.30,
p = 0.005), controlling impulses (r = 0.24, p = 0.024),
acceptance of emotions (r = 0.43, p < 0.0001), access to
ER strategies (r = 0.27, p = 0.013) and goal-oriented action
(r = 0.31, p = 0.004).
An explorative backward regression analysis with these
variables resulted in a significant model [F(2,41) = 17.55,
p < 0.0001, R2 = 0.461]. The model consisted of two subscales
of the DERS: improvement in Non-acceptance of emotions
(β = 0.556, t = 4,39, p < 0.0001) and improvement in
Difficulties with goal-oriented actions (β = 0.220, t = 1,739,
p = 0.09) explaining 46,1% of the variance in anxiety
symptom reduction.
The post hoc ANCOVA on anxiety level showed a
significant interaction [F(1,22) = 29,52, p < 0.0001, η2p = 0.57]
between Test moment (pre vs. post treatment) and the
covariate reduction of difficulties in ER, reflecting that
larger anxiety reduction was highly associated with larger
improvement in ER.
Baseline Factors That Influence the
Success of Treatment
The LWASQ difference score (pre–post treatment) was corre-
lated with age, duration of anxiety, number of comorbidities,
education, familiarity with AT or anthroposophic healthcare,
pre-treatment levels of anxiety (LWASQ), QoL (MANSA),
ER (DERS), distress, depression and somatization (4DKL). Only
pre-treatment levels of anxiety (r = 0.38, p < 0.0001) and ER
(r = 0.25, p = 0,017) showed a significant correlation with therapy
success (anxiety reduction).
A regression analysis (Method = Enter) resulted in a
significant model [F(2,41) = 6.30, p = 0.004, R2 = 0.235] with
pre-treatment level of anxiety (β = −0.350; t = −2.33) and pre-
treatment ER score (β = −0.220; t = −1.46), together explaining
23,5% of the variance in anxiety symptom reduction.
DISCUSSION
Summary of Outcomes
This study is the first RCT that studied an AT intervention
for GAD, SAD, and PD. For this reason and because
anthroposophic AT as a complex intervention is adjusted to
the needs of individual patients, the RCT had a pragmatic
character. To evaluate the intervention as provided in clinical
practice, therapists were allowed to deploy the treatment
as they would normally do. The tested intervention was
executed by trained AAT professionals who are able to
individualize the treatment within the boundaries of the
described goals, means and exercises, based on consensus
within the professional organization. Artistic exercises with clay,
drawing, and painting were used in every case to work on
anxiety reduction. The most used medium was drawing in
particular shape drawing, often as ‘warming-up’ and also as
homework exercises. The second most used medium was clay
work): the modeling of a sphere or other round shapes and
metamorphosis series of platonic solids were the most frequent
deployed exercises.
The outcomes show that 10–12 sessions of AT lead to
a significant decrease of anxiety symptoms, as well as a
significant improvement in QoL and remained at 3 months
follow-up. Significant improvements were also observed with
respect to access to emotion regulation strategies. Improvements
in ER were highly associated with anxiety reduction: the ER
aspects acceptance of emotions and improved goal-oriented action
accounted for 46% of the improvement in anxiety symptom
severity. Participants with higher pre-treatment anxiety scores
and those who experienced many difficulties in ER pre-treatment
showed the largest improvements.
Interpretation and Comparison to
Literature
Effects of AT on anxiety in adults have been suggested in other
studies (Sandmire et al., 2012; Moayer Toroghi, 2015; Zhan Yu
et al., 2016), although these studies have methodological issues
resulting in a high risk of bias (Abbing et al., 2018) and do not
concern subjects with specific or diagnosed ADs.
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Anxiety symptoms are related to less effective ER (Suveg and
Zeman, 2004; Mennin et al., 2005). The association of improved
ER with anxiety reduction in our study is in line with results from
various studies which show that a decrease of anxiety is related to
improvement of ER (Cisler and Olatnuji, 2012). Our RCT showed
that ER is a factor that influences anxiety reduction through AT.
The improvements in ER that had the largest influence were o
better acceptance of emotions and improved goal-oriented action.
Usually, ER training focuses on strategies that minimize negative
emotions and/or maximize positive emotions (Koole and Aldao,
2016). These strategies largely fall within need-oriented ER and
appear to provide limited contributions to psychological health
(Aldao and Nolen-Hoeksema, 2012). Instead, Koole and Aldao
(2016) argue that the focus should be more toward goal-oriented
ER and person-oriented ER, to learn to apply strategies more
flexibly and adaptively. The improvement of goal-oriented action
in our study suggests that AT promotes goal-oriented ER. AT
may also improve person-oriented ER, since to gain acceptance of
emotions, it is needed to face the emotion and to endure this. This
could be easier and less threatening if the emotion can be faced in
externalized form, which is the case in art work (Haeyen, 2018).
Higher pre-treatment scores of anxiety were predictive of
therapy success. This seems plausible, because the higher the
score, the more room for improvement. Another possible
explanation is that AT is most suitable for patients with severe
anxiety symptoms.
Strengths and Limitations
The strength of this study is the RCT design, being used to
study the effectiveness of AT in reducing anxiety in subjects with
ADs for the first time. Other strengths are the broad inclusion
criteria that were used, to assess whether the intervention could
be helpful to most women with moderate to high levels of anxiety
symptoms (dimensional approach), and not just to a narrow
diagnostic subgroup.
The set of relevant outcome variables (anxiety symptom
level, QoL, and ER) enabled us to explore a possible working
mechanism. The strength of the LWASQ is that it is able to
measure both cognitive, behavioral, as well as somatic aspects of
anxiety. This enabled us to investigate in what area of anxiety the
improvements occurred. A limitation is that this instrument is
not as commonly used in effectiveness studies on anxiety as the
State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1983).
Our outcomes are therefore not easy to compare to (anxiety)
outcomes of other studies.
A more important limitation is the risk on performance bias
as blinding is not feasible in AT, like in other psychotherapeutic
interventions. According to Munder and Barth (2017), the risk
can be lowered by using an active treatment as control. We
used a waitlisted (inactive) control group, which is the most
logical first step in this young research domain. A placebo
effect may therefore have biased the results in that the effect
of treatment may be overestimated. Important aspects that may
have influenced the observed effectiveness are expectations and
motivation of the participants. Positive expectations lead to more
positive self-evaluation. It is likely that the study population
consisted of women who have (at least some) affinity with
creativity and/or art making, because the participants applied
for this trial themselves. This resulted in a study population
that might have had positive expectations of the therapy. It
is estimated that a positive expectation causes 15% of the
effects of psychotherapy (Asay and Lambert, 1999), because
these expectations can lead to a more positive self-evaluation
of mental health (Taylor and Brown, 1988). Motivation is
also known to be an important factor in therapy success
(Gordon, 1976; Hubble et al., 1999) and contributes to the
improvement of general health and wellbeing (e.g., Deci et al.,
1991; Miller et al., 1993; Pelletier et al., 1997). Thus, the
therapeutic effect of AT may be somewhat overestimated in
our study. In psychotherapy it is argued that ‘treatment’ leads
to better outcomes than ‘no treatment,’ due to non-specific
treatment factors (e.g., empathy, warmth, attention) (Wampold,
2001; Bjornsson, 2011). It might therefore be obvious that the
AT participants improved compared to the WL participants.
However, based on the work by Kiene (2013), there are some
arguments that support the hypothesis that the observed effects
are not only caused by non-specific treatment factors, but
can (partly) be attributed to the specific effect of AT: the
effect size is large, the effect occurs relatively fast (within 3
months, compared to the mean duration of anxiety of 17.6
years), the effects remain at follow-up (3 months), the effects
were repeated in the second treatment group (the previous
WL group), and there is evidence of a rational working
mechanism (AT contributes to better acceptance of emotions
and improved goal-oriented action, leading to improvement
of ER skills) that is in line with AT expertise and literature.
Another important limitation is that our study does not
provide insight in the specific AT factors that contributed to
the observed effects. Our study provides some information
about the content of the intervention, but treatment goals
from the list are not connected to general accepted theories
and a rationale for the deployed artistic exercises cannot be
provided at this point. This should be subject of future studies,
aimed at further opening-up the black-box of AT. A final
limitation is that we were not able to perform subgroup
analyses per subtype of anxiety, due to small subgroups and
overlap in diagnostic groups, since multiple diagnosis applied
to all subjects.
Generalizability
The study of a complex intervention, utilizing customized
care within a range set by professionals, strengthens the
external validity of the results. The study population consisted
mainly of moderate to highly educated women, with multiple
anxiety diagnoses, moderate to severe anxiety symptoms and
a long duration of symptoms. Individuals with high levels
of anxiety, comorbidity and a long duration of symptoms
generally have low therapy success rates (e.g., Mululo et al.,
2012). The outcomes of our study indicate that this complex
population benefited from AT, indicating that AT can be
an option for this specific group of patients, and might
also be beneficial for less complex anxiety patient groups.
Anthroposophic AT is a treatment that is tailored to the
individual, with could partially explain the positive results:
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patients with severe symptoms, comorbidities and a chronic
course appear to be better treatable with a therapy that is
adapted to the individual, in terms of intensity and focus
(Newman et al., 2013).
Participants applied for this trial themselves. It is therefore
likely that the study population consisted of women who
have (at least some) affinity with creativity and/or art making
and were motivated to try this therapy. It is not clear if
the results are generalizable to less motivated women with
anxiety. Since only women were included, the results are not
generalizable to men.
The tested AT intervention was only executed by trained AAT
professionals who are able to individualize the treatment within
the boundaries of the described goals, means and exercises, based
on consensus within the professional organization. Therefore the
tested intervention is representative of for the AAT treatment
of anxiety. Based on the encouraging results of our study,
AT as an optional treatment for anxiety can be continued in
clinical practice.
Future Perspectives
Further studies are needed to strengthen the evidence base for
AT in the treatment of anxiety. Studies with active controls are
recommended, since this reduces the risk of bias due to the lack of
blinding. A sham treatment could correct for the effect of ‘being
treated.’ AT should also be compared to treatment as usual (e.g.,
CBT). To assess the long-term effects of AT, longer follow-up
periods (>6 months) are needed.
In future RCTs, the inclusion criteria may be narrowed
down to further explore the effects of AT on specific ADs.
The use of more objective measures, like physiological measures
of anxiety, in addition to the present measures are also
recommended. In future studies executive functioning may be
included to further unravel the working mechanisms of AT
as it is known that EF is negatively influenced by anxiety
(Fujii et al., 2013).
Further studies aimed at the therapeutic content of AT
are needed to provide insight into AT-specific factors that
contribute to the observed effects. AAT could also be compared
to other types of AT. Studying the cost-effectiveness of AT
compared to treatment as usual (CBT, pharmacotherapy,
or a combination of both), is important to ascertain the
contribution of AT to value-based healthcare. Finally,
client experiences, obtained through in-depth interviews,
can give additionally insight in the subjective value of this
treatment for patients and the specific treatment factors that
contribute to the reduction of anxiety symptoms and the
improvement of QoL.
CONCLUSION
(1) Three months (10–12 sessions) AT is superior to WL
condition in reducing anxiety symptoms and improving
QoL in adult women with ADs GAD, SAD and/or PD
and moderate to severe anxiety symptoms. These effects
remain at 3 months follow-up.
(2) Positive changes in ER, especially in the acceptance of
emotions and in improved goal-oriented action,
account for 46% of the reduction of anxiety
symptom severity.
(3) To obtain high quality evidence for effectiveness of AT,
RCTs with active controls (treatment as usual) and RCTs
on cost-effectiveness are needed.
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